Clinical Trial Update: Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function [Phase 1]

View source ↗

Summary

Phase 1 trial update for Xenin-25 assessing its effect on insulin secretion and beta-cell function in Type 2 diabetes mellitus; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Xenin-25

Snippet

Sponsor: Washington University School of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED